| Nomograms to predict outcomes after 177Lu-PSMA therapy in men with metastatic castration-resistant prostate cancer: an international, multicentre, retrospective study A Gafita, J Calais, TR Grogan, B Hadaschik, H Wang, M Weber, S Sandhu, ... The Lancet Oncology 22 (8), 1115-1125, 2021 | 145 | 2021 |
| qPSMA: semiautomatic software for whole-body tumor burden assessment in prostate cancer using 68Ga-PSMA11 PET/CT A Gafita, M Bieth, M Krönke, G Tetteh, F Navarro, H Wang, E Günther, ... Journal of Nuclear Medicine 60 (9), 1277-1283, 2019 | 98 | 2019 |
| Novel framework for treatment response evaluation using PSMA PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study A Gafita, I Rauscher, M Weber, B Hadaschik, H Wang, WR Armstrong, ... Journal of Nuclear Medicine 63 (11), 1651-1658, 2022 | 75 | 2022 |
| Endogenous danger signals trigger hepatic ischemia/reperfusion injury through toll-like receptor 4/nuclear factor-kappa B pathway W Hui, Z Li, H Wu, W Yang, C Jiang, Q Zheng, J Zhang Chinese medical journal 120 (6), 509-514, 2007 | 60 | 2007 |
| Tumor sink effect in 68Ga-PSMA-11 PET: myth or reality? A Gafita, H Wang, A Robertson, WR Armstrong, R Zaum, M Weber, ... Journal of Nuclear Medicine 63 (2), 226-232, 2022 | 50 | 2022 |
| Efficacy and safety of 177Lu-labeled prostate-specific membrane antigen radionuclide treatment in patients with diffuse bone marrow involvement: a multicenter retrospective study A Gafita, WP Fendler, W Hui, S Sandhu, M Weber, R Esfandiari, J Calais, ... European Urology 78 (2), 148-154, 2020 | 47 | 2020 |
| Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria A Gafita, I Rauscher, WP Fendler, V Murthy, W Hui, WR Armstrong, ... European Journal of Nuclear Medicine and Molecular Imaging 49 (12), 4271-4281, 2022 | 46 | 2022 |
| The added value of PSMA PET/MR radiomics for prostate cancer staging EL Solari, A Gafita, S Schachoff, B Bogdanović, A Villagrán Asiares, ... European journal of nuclear medicine and molecular imaging 49 (2), 527-538, 2022 | 46 | 2022 |
| Bone marrow and non-bone marrow TLR4 regulates hepatic ischemia/reperfusion injury W Hui, Z Jinxiang, W Heshui, L Zhuoya, Z Qichang Biochemical and biophysical research communications 389 (2), 328-332, 2009 | 34 | 2009 |
| Regional lymph node metastasis on prostate specific membrane antigen positron emission tomography correlates with decreased biochemical recurrence-free and therapy-free … T Amiel, C Würnschimmel, M Heck, T Horn, N Nguyen, L Budäus, ... The Journal of Urology 205 (6), 1663-1670, 2021 | 28* | 2021 |
| Connexin 43 remodeling induced byLMNAgene mutationGlu82Lysin familial dilated cardiomyopathy with atrial ventricular block L Sun, W Lin, W Hui, Y Zhang, J Pu Chinese medical journal 123 (8), 1058-1062, 2010 | 25 | 2010 |
| TLR2 mRNA upregulation in ischemic lobes in mouse partial hepatic ischemia/reperfusion injury model Z Jinxiang, W Heshui, W Lin, Z Jinhui, W Hui, Z Qichang Journal of Huazhong University of Science and Technology [Medical Sciences …, 2004 | 18 | 2004 |
| Evaluation of SUV normalized by lean body mass (SUL) in 68Ga-PSMA11 PET/CT: a bi-centric analysis A Gafita, J Calais, C Franz, I Rauscher, H Wang, A Roberstson, J Czernin, ... EJNMMI research 9, 1-6, 2019 | 16 | 2019 |
| Utility of 18F-rhPSMA-7.3 positron emission tomography for imaging of primary prostate cancer and pre-operative efficacy in N-staging of unfavorable intermediate to very high … T Langbein, H Wang, I Rauscher, M Krönke, K Knorr, A Wurzer, ... Journal of Nuclear Medicine, 2022 | 13 | 2022 |
| PSMA-ligand uptake can serve as a novel biomarker in primary prostate cancer to predict outcome after radical prostatectomy H Wang, T Amiel, C Würnschimmel, T Langbein, K Steiger, I Rauscher, ... EJNMMI research 11 (1), 76, 2021 | 11 | 2021 |
| Laparoscopic partial nephrectomy for T1a renal tumors is safe and feasible W Hui, Z Gao, C Lin, J Wu, W Lin, J Wang, D Sun, W Ke, Q Yu Chinese Medical Journal 124 (15), 2243-2247, 2011 | 11 | 2011 |
| The influence of specific activity on the biodistribution of 18F-rhPSMA-7.3: a retrospective analysis of clinical PET data T Langbein, A Wurzer, A Gafita, A Robertson, H Wang, A Arçay, M Herz, ... Journal of Nuclear Medicine 63 (5), 742-745, 2022 | 9 | 2022 |
| EORTC risk tables are more suitable for Chinese patients with nonmuscle-invasive bladder cancer than AUA risk stratification H Wang, W Ding, G Jiang, Y Gou, C Sun, Z Chen, K Xu, G Xia Medicine 97 (36), e12006, 2018 | 8 | 2018 |
| Exceptional 4-year response to 177Lu-PSMA radioligand therapy in metastatic castration-resistant prostate cancer A Gafita, H Wang, R Tauber, C D’Alessandria, WA Weber, M Eiber European Journal of Nuclear Medicine and Molecular Imaging 46, 2212-2213, 2019 | 7 | 2019 |
| Mimics 三维重建模型在人体解剖学学习中的应用 王卉， 吴涛 中国医学教育技术 26 (6), 664-667, 2012 | 6 | 2012 |
